Compounds > galantamine

galantamine and Palsy

galantamine has been researched along with Palsy in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di, R; Lawton, MA; Long, C; Wang, H; Wang, Y; Wu, WH; Xin, L; Yamujala, R1
Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT1
SKLIAROVA, TU1
GEORGIEV, I; MILEV, M; SEDLOEV, S1
MOIRAGHI, P1
Göpel, W1
Batskusheb, S; Mtsmkob, B1

Trials

1 trial(s) available for galantamine and Palsy

ArticleYear
[Nivaline in neurological therapy (report of 100 cases)].
    Psychiatrie, Neurologie, und medizinische Psychologie, 1971, Volume: 23, Issue:12

    Topics: Adult; Aged; Central Nervous System Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Galantamine; Humans; Injections, Subcutaneous; Male; Neuromuscular Diseases; Paralysis; Peripheral Nervous System Diseases

1971

Other Studies

6 other study(ies) available for galantamine and Palsy

ArticleYear
Acetylcholineestarase-inhibiting alkaloids from Lycoris radiata delay paralysis of amyloid beta-expressing transgenic C. elegans CL4176.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Acetylcholinesterase; Alzheimer Disease; Amaryllidaceae Alkaloids; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Gene Expression; Humans; Longevity; Lycoris; Oxidative Stress; Paralysis; Peptide Fragments; Phenanthridines

2013
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors

2009
[On treatment of paralyses of the ocular muscles with Nivaline].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1962, Volume: 62

    Topics: Galantamine; Humans; Ophthalmoplegia; Paralysis; Parasympathomimetics

1962
ON THE EFFECT OF NIVALIN UPON INTESTINAL PERISTALSIS.
    Nauchni trudove na Visshiia meditsinski institut, Sofiia, 1964, Volume: 43

    Topics: Drug Therapy; Galantamine; Gastrointestinal Motility; Humans; Intestinal Diseases; Intestine, Small; Intestines; Paralysis; Peristalsis; Postoperative Complications; Toxicology; Urinary Bladder Diseases

1964
[Nivaline therapy in residual hemiparesis from cerebral vascular disorders].
    Gazzetta medica italiana, 1962, Volume: 121

    Topics: Anticholesteremic Agents; Cerebrovascular Disorders; Galantamine; Humans; Intracranial Arteriosclerosis; Paralysis; Paresis

1962
[Nivalin in rehabilitation of residual paralysis after cerebrovascular accidents].
    Folia medica, 1970, Volume: 12, Issue:1

    Topics: Adult; Aged; Cerebrovascular Disorders; Drug Synergism; Female; Galantamine; Humans; Male; Middle Aged; Paralysis; Time Factors; Triazines

1970